Nantahala Capital Management, LLC Syndax Pharmaceuticals Inc Call Options Transaction History

Nantahala Capital Management, LLC

  • $1.68 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$14.52 - $21.77 $2.9 Million - $4.35 Million
200,000 New
200,000 $2.9 Million
Q3 2022

Nov 10, 2022
BUY
$18.51 - $24.79 $555,300 - $743,700
30,000 New
30,000 $721,000
Q4 2021

Feb 14, 2022
BUY
$15.23 - $22.47 $3.05 Million - $4.49 Million
200,000 New
200,000 $4.38 Million

Others Institutions Holding SNDX

# of Institutions
228
Shares Held
89.9M
Call Options Held
1.01M
Put Options Held
692K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $802M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email